Pathstone Holdings’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-143,719
Closed -$2.22M 2201
2025
Q1
$2.22M Sell
143,719
-591,123
-80% -$9.03M 0.01% 923
2024
Q4
$11.2M Sell
734,842
-88,754
-11% -$1.43M 0.05% 269
2024
Q3
$13.5M Sell
823,596
-1,185,492
-59% -$19.4M 0.06% 236
2024
Q2
$33M Sell
2,009,088
-276,902
-12% -$4.45M 0.15% 99
2024
Q1
$38.1M Buy
2,285,990
+133,758
+6% +$2.07M 0.18% 84
2023
Q4
$32.2M Buy
+2,152,232
New +$31.3M 0.17% 91

Other funds holding BCAT

Pathstone Holdings's BCAT Position: Q2 2025 in Review

Pathstone Holdings sold out of BlackRock Capital Allocation Term Trust (BCAT) in Q2 2025, closing a stake of 143,719 shares — an estimated $2.22M sold.

Pathstone Holdings first reported a position in BCAT in Q4 2023 and held it in 6 quarters. The position peaked at $38.1M in Q1 2024. 91 funds tracked by Wall St. Rank hold BCAT as of Q2 2025.

  • Pathstone Holdings reported no remaining BlackRock Capital Allocation Term Trust position as of Q2 2025 after selling out during the quarter.
  • Pathstone Holdings sold 143,719 BlackRock Capital Allocation Term Trust shares in Q2 2025, an estimated $2.22M.
  • Pathstone Holdings first reported a position in BlackRock Capital Allocation Term Trust in Q4 2023 and held it in 6 quarters.
  • Pathstone Holdings's BlackRock Capital Allocation Term Trust position peaked at $38.1M in Q1 2024.
  • 91 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q2 2025.

Based on Pathstone Holdings's 13F filing for Q2 2025, filed 12 Aug 2025.